At the National Assemblée du Québec, the Premier of Quebéc, Francois Legault inducted Dr. Philippe Gros has a Chevalier on June 20, 2019 within the Ordre National du Québec.

Dr. Philippe Gros is widely acknowledged as an expert in genetic studies using mouse models, and has greatly contributed to knowledge about the fundamental causes of human illnesses, including genetic susceptibility to infections, predisposition to neural tube defects, and carcinogen-induced cancer. Dr. Gros obtained his Ph.D. From McGill in 1983. Under his leadership, a research team identified the gene that causes spina bifida, the second-most common birth defect in humans. He has also advanced knowledge regarding genes that give rise to susceptibility to malaria, which affects over 200 million people annually worldwide (WHO). Prof. Gros’s laboratory continues to use genetic models to assist in the development of more effective anti-microbial drugs.

In 2003, he became a fellow of the Academy of Sciences, Life Science Division, of the Royal Society of Canada. In 2008, he received the Wilder Penfield Prize for Health Sciences (Prix du Québec) and in 2009 Prof. Gros was awarded the Killam Prize for distinguished Canadian scholars in the field of health sciences. He is a member of the International Tuberculosis Centre and the Goodman Cancer Research Centre. He also serves as Director of the Complex Traits Program at McGill. He received the Queen Elizabeth II Diamond Jubilee Medal from the Association of Universities and Colleges of Canada from the The Governor General of Canada in 2013.